Published in Am J Physiol Regul Integr Comp Physiol on December 26, 2007
The effects of arginase inhibitor on lung oxidative stress and inflammation caused by pneumoperitoneum in rats. BMC Anesthesiol (2015) 1.39
Robot-assisted laparoscopic urological surgery in children. Nat Rev Urol (2013) 0.78
Nitric oxide synthase inhibition aggravates the adverse renal effects of high but not low intraabdominal pressure. Surg Endosc (2009) 0.78
The risk of acute kidney injury following laparoscopic surgery in a chronic kidney disease patient. NDT Plus (2011) 0.75
Renal Perfusion and Function during Pneumoperitoneum: A Systematic Review and Meta-Analysis of Animal Studies. PLoS One (2016) 0.75
Effect of Pneumoperitoneum on Oxidative Stress and Inflammation via the Arginase Pathway in Rats. Yonsei Med J (2016) 0.75
Serum cystatin C is a sensitive early marker for changes in the glomerular filtration rate in patients undergoing laparoscopic surgery. Clinics (Sao Paulo) (2014) 0.75
Effect of Pneumoperitoneum on Renal Function and Physiology in Patients Undergoing Robotic Renal Surgery. Curr Urol (2016) 0.75
The effects of combined epidural and general anesthesia on the autonomic nervous system and bioavailability of nitric oxide in patients undergoing laparoscopic pelvic surgery. Surg Endosc (2012) 0.75
A 3'-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol (2011) 2.95
Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr (2004) 2.17
Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J Nucl Med (2007) 2.15
Venous trauma in the Lebanon War--2006. Interact Cardiovasc Thorac Surg (2007) 2.07
Multidetector CT angiography of peripheral vascular disease: a prospective comparison with intraarterial digital subtraction angiography. AJR Am J Roentgenol (2003) 1.40
Duplex ultrasound verified by angiography in patients with severe primary and restenosis of internal carotid artery. Ann Vasc Surg (2006) 1.40
Abdominal aortic aneurysm in Behçet's disease: new treatment options for an old and challenging problem. Isr Med Assoc J (2004) 1.40
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. Breast Cancer Res Treat (2007) 1.30
Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer (2007) 1.21
Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Pharmacol Ther (2004) 1.09
Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Cancer (2004) 1.07
Carotid plaque vulnerability: quantification of neovascularization on contrast-enhanced ultrasound with histopathologic correlation. AJR Am J Roentgenol (2011) 0.99
Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancer. Cancer Lett (2011) 0.99
Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy. J Biomed Biotechnol (2011) 0.98
Delayed recovery of renal regional blood flow in diabetic mice subjected to acute ischemic kidney injury. Am J Physiol Renal Physiol (2007) 0.93
Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation (2002) 0.93
Multidetector CT angiography in the evaluation of acute mesenteric ischemia. Eur Radiol (2008) 0.93
Impact of pneumoperitoneum on renal perfusion and excretory function: beneficial effects of nitroglycerine. Surg Endosc (2008) 0.93
Induction of cardiac hypertrophy by a controlled reproducible sutureless aortocaval shunt in the mouse. J Invest Surg (2005) 0.90
Cancer-related transcriptional targets of the circadian gene NPAS2 identified by genome-wide ChIP-on-chip analysis. Cancer Lett (2009) 0.89
Let-7a regulation of insulin-like growth factors in breast cancer. Breast Cancer Res Treat (2010) 0.89
The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality. Biochem Pharmacol (2009) 0.87
Porcine small diameter arterial extracellular matrix supports endothelium formation and media remodeling forming a promising vascular engineered biograft. Tissue Eng Part A (2011) 0.86
Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant (2008) 0.86
Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Proc Natl Acad Sci U S A (2003) 0.85
Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol (2013) 0.85
Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. Mutat Res (2007) 0.85
Urinary NGAL and KIM-1: biomarkers for assessment of acute ischemic kidney injury following nephron sparing surgery. J Urol (2012) 0.84
Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model. Cardiovasc Diabetol (2003) 0.84
Intraluminal pyogenic granuloma of the basilic vein: color duplex sonographic manifestations. J Ultrasound Med (2004) 0.83
Large A-V fistula: pathophysiological consequences and therapeutic perspectives. Curr Vasc Pharmacol (2003) 0.83
Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome. Am J Physiol Renal Physiol (2007) 0.83
Minimally invasive surgery for treatment of hyperparathyroidism. Isr Med Assoc J (2005) 0.83
Involvement of the endothelin and nitric oxide systems in the pathogenesis of renal ischemic damage in an experimental diabetic model. Life Sci (2012) 0.83
Effects of chronic rosiglitazone treatment on renal handling of salt and water in rats with volume-overload congestive heart failure. Circ Heart Fail (2011) 0.82
Percutaneous ultrasonographically guided thrombin injection of iatrogenic pseudoaneurysms in unusual sites. J Ultrasound Med (2003) 0.81
Differential regulation of ET(A) and ET(B) in the renal tissue of rats with compensated and decompensated heart failure. J Cardiovasc Pharmacol (2004) 0.81
Are bile acids involved in the renal dysfunction of obstructive jaundice? An experimental study in bile duct ligated rats. Ren Fail (2004) 0.80
Nephroprotective effects of TVP1022, a non-MAO inhibitor S-isomer of rasagiline, in an experimental model of diabetic renal ischemic injury. Am J Physiol Renal Physiol (2013) 0.80
Kidney-ear axis. Isr Med Assoc J (2007) 0.80
Laparoscopic diagnostic peritoneal lavage (L-DPL): A method for evaluation of penetrating abdominal stab wounds. World J Emerg Surg (2006) 0.80
PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft. Mol Imaging Biol (2003) 0.80
Hypothenar hammer syndrome: apropos of six cases and review of the literature. Vascular (2009) 0.79
Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure. Am J Physiol Renal Physiol (2007) 0.79
[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Harefuah (2008) 0.79
Pharmacogenomic, physiological, and biochemical investigations on safety and efficacy biomarkers associated with the peroxisome proliferator-activated receptor-gamma activator rosiglitazone in rodents: a translational medicine investigation. J Pharmacol Exp Ther (2010) 0.79
Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.79
Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic Biol Med (2008) 0.79
Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure. Am J Physiol Heart Circ Physiol (2005) 0.79
[Neutrophil gelatinase-associated lipocalin (NAGL): a novel biomarker for acute kidney injury]. Harefuah (2011) 0.79
Renal effects of human urotensin-II in rats with experimental congestive heart failure. Nephrol Dial Transplant (2006) 0.78
Vascular injuries in an urban combat setting: experience from the 2006 Lebanon war. Vascular (2010) 0.78
Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure. Clin Sci (Lond) (2002) 0.78
Cryosurgery of close or positive margins after hepatic resection for primary and metastatic hepatobiliary malignancies. Am Surg (2002) 0.78
Nitric oxide synthase inhibition aggravates the adverse renal effects of high but not low intraabdominal pressure. Surg Endosc (2009) 0.78
Management of combat vascular injuries using modern imaging: are we getting better? Emerg Med Int (2013) 0.77
Preoperative cerebral hemodynamics and shunting during carotid endarterectomy in patients with severe unilateral carotid stenosis. J Clin Ultrasound (2007) 0.76
Cardiac and renal effects of omapatrilat, a vasopeptidase inhibitor, in rats with experimental congestive heart failure. Am J Physiol Heart Circ Physiol (2004) 0.76
Alveolar fluid reabsorption is increased in rats with compensated heart failure. Am J Physiol Lung Cell Mol Physiol (2006) 0.76
Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide. Surg Endosc (2013) 0.76
Vasopressin-2 receptor antagonist attenuates the ability of the lungs to clear edema in an experimental model. Am J Respir Cell Mol Biol (2012) 0.76
Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure. J Pharmacol Exp Ther (2008) 0.76
Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure. J Cardiovasc Pharmacol (2004) 0.75
Potential early predictors for outcomes of experimental hemorrhagic shock induced by uncontrolled internal bleeding in rats. PLoS One (2013) 0.75
[Therapeutic implications of endothelin antagonists for cardiovascular diseases]. Harefuah (2004) 0.75
[Vasopressin V2 receptor antagonists: pharmacological properties and clinical implications]. Harefuah (2005) 0.75